Top Pharmaceutical Companies in Baltimore, MD (9)
Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more than 21,000 global professionals collaborates with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical...
Parexel's Top Stability & Growth Strengths
Strong Revenue Growth: Revenue is reported to have risen, with sustained mid-single-digit growth projected as demand from large pharmaceutical and biotechnology clients remains firm. This points to steady topline momentum rather than sporadic spikes.
Strong Market Position & Advantage: Net new business awards surged year over year and drove a record backlog near $9.4 billion. Such contract momentum indicates durable demand and competitive positioning across key sponsor segments.
Investor Backing & Capital Strength: The financial outlook was revised to Stable by S&P Global Ratings, citing strong liquidity, successful deleveraging, and expected margin recovery, alongside backing from EQT and Goldman Sachs. These factors underpin access to capital and financial resilience.
Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) whose mission is to develop, manufacture, and supply products that help people live better and healthier lives. Catalent is dedicated to delivering unparalleled service to pharma, biotech, and consumer health customers, supporting product development, launch, and full life-cycle supply. With time-tested experience in development sciences, delivery technologies, and...
Catalent, Inc.'s Top Stability & Growth Strengths
Strong Market Position & Advantage: Independent analyses consistently place Catalent among the top global CDMOs, with meaningful presence in outsourced finished‑dose approvals and a broad end‑to‑end network. Its scale across oral, sterile, biologics, and cell & gene therapy supports late‑stage and commercial programs globally.
Investor Backing & Capital Strength: Novo Holdings’ completed acquisition provides deep‑capital sponsorship and strategic validation, with U.S./EU clearance reinforcing the platform’s importance. Related transactions around sterile sites highlight the strategic value of capabilities aligned to high‑demand medicines.
Future-Ready Strategy: Private ownership and a refreshed operating model aim to focus investment on biologics, cell & gene therapy, and clinical supply. GLP‑1–linked demand signals and capacity plans into the coming years indicate preparedness for sustained growth.
Magellan Health is a leader in managing the fastest growing, most complex areas of health, including special populations, complete pharmacy benefits and other specialty areas of healthcare. Magellan supports innovative ways of accessing better health through technology, while remaining focused on the critical personal relationships that are necessary to achieve a healthy, vibrant life. Magellan's customers include health plans and...
RelaDyne, headquartered in Cincinnati, OH, combines many years of expertise with our valued associates to serve more than 10,000 clients in the automotive, commercial and industrial industries. We strive to deliver valuable, dependable service and effective solutions as a trusted partner to our customers. Our core business, focused on lubrication excellence, is accomplished through offering unmatched products and services in which...
RelaDyne LLC's Top Stability & Growth Strengths
Strong Market Position & Advantage: The company is widely cited as the nation’s largest lubricant distributor with leadership across lubricants, fuels/DEF, and industrial reliability services. Its standing in a fragmented market and industry recognition signal durable competitive advantages with large industrial and commercial clients.
Market Expansion: Feedback suggests sustained geographic growth to 190+ locations driven by an active acquisition program, including multiple deals in 2025–2026 that extend coverage across the West Coast, Midwest, and Northeast. The relocation of headquarters to Houston is framed as supporting additional scale, job growth, and proximity to key partners.
Investor Backing & Capital Strength: Private‑equity ownership and portfolio materials describing multibillion‑dollar scale indicate resources to continue organic expansion and M&A. This backing is repeatedly linked to momentum for further acquisitions and network densification.
BioIVT supplies human and animal biospecimens, including tissues, cells and biofluids, alongside ADME-Tox products and specialized research services. Its samples and models support biomedical research, drug discovery and development, diagnostic development, and precision medicine research. By pairing biological materials with clinical donor data, the company helps pharmaceutical, biotechnology, academic and diagnostic researchers investigate disease, assess drug metabolism and toxicity, and...
Omnicare is a pharmacy services provider for long-term care and post-acute facilities, as well as assisted living or senior living communities.
Fzata, Inc. is a pre-clinical stage biopharmaceutical company based in Halethorpe, MD within the vibrant BioHealth Capital Region. Fzata’s vision is to reduce health inequities by expanding patient access to therapeutic biologics. This is made possible with our proprietary first-in-class oral Bioengineered Probiotic Yeast Medicines (BioPYM™) platform. BioPYM enables orally administered yeast micro-factories to make biologic therapeutics “on-site” in the...
When you donate blood plasma, you help create life-changing medicines, while putting a little extra money in your pocket at the same time.
Brinkbit is a fast, extensible, and scalable BaaS platform for game services, content management, live ops, and more!















